3 employees
Swiftscale Biologics uses cell-free protein synthesis to enable the next generation of protein therapeutics.
2019
$11M
from 2 investors over 2 rounds
Swiftscale Biologics raised $11M on June 1, 2020
Investors: 8VC
Swiftscale Biologics raised $4M on June 1, 2019